Wellcome Trust Sanger Institute and Applied Biosystems Ally on Cancer Genetic Research
Scientists will use five SOLiD™ Systems from Applied Biosystems to sequence the genome of a small cell lung cancer cell line and a noncancerous cell line. Scientists from Sanger and Applied Biosystems plan to increase sequence coverage of both genomes by identifying one SNP for every 500,000 bases of DNA. One of the goals of this research is to generate 20-fold genome coverage of the cancer genome as well as the normal DNA using paired-end reads of a wide range of insert sizes.
This entry was posted on Thursday, May 1st, 2008 at 10:51 am and is filed under Research, Small-Cell. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.